Chronic cutaneous leishmaniasis in an immunocompetent patient: Response to miltefosine [11]

Journal of the European Academy of Dermatology and Venereology

Volumn 21, Issue 5, 2007, Pages 695-696

  Ruiz Villaverde, R ^a   Sanchez Cano D ^b   Villaverde Gutierrez, C ^a  

^a Dermatology Unit   (Spain)

^b HOSPITAL UNIVERSITARIO SAN CECILIO   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; MEGLUMINE ANTIMONATE; MILTEFOSINE;

ADULT; AMASTIGOTE; CASE REPORT; CELL INFILTRATION; CHRONIC DISEASE; DRUG RESPONSE; ERYTHEMA; HISTIOCYTE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOCOMPETENCE; LEISHMANIA INFANTUM; LETTER; MACROPHAGE; MALE; MONONUCLEAR CELL; PARASITE IDENTIFICATION; PLASMA CELL; PRIORITY JOURNAL; SKIN INDURATION; SKIN INFECTION; SKIN LEISHMANIASIS; SKIN MANIFESTATION;

ADMINISTRATION, ORAL; ANTIPROTOZOAL AGENTS; HUMANS; LEISHMANIASIS, CUTANEOUS; MALE; MIDDLE AGED; PHOSPHORYLCHOLINE;

EID: 34250328635     PISSN: 09269959     EISSN: 14683083     Source Type: Journal    
DOI: 10.1111/j.1468-3083.2006.01990.x     Document Type: Letter

References (5)

1. Soto J, Arana BA, Toledo J, Rizzo N, Vega JC, Diaz A et al. Miltefosine for New World cutaneous leishmaniasis. Clin Infect Dis 2004; 38: 1266-1272.
2. Karincaoglu Y, Esrefoglu M, Oxcan H. Atypical form of cutaneous leishmaniasis: Erysipeloid form. Int J Dermatol 2004; 43: 827-829.
3. Motta AC, Arruda D, Souza CS, Foss NT. Disseminated mucocutaneous leishmaniasis resulting from chronic use of corticosteroid. Int J Dermatol 2003; 42: 703-706.
4. Gangneux JP, Menotti J, Lorenzo F et al. Prospective value of PCR amplification and sequencing for diagnosis and typing of Old World Leishmania infections in the area of nonendemicity. J Clin Microbiol 2003; 41: 1419-1422.
5. Murray HW, Berman JD, Davies CR, Sarabia NG. Advances in leishmaniasis. Lancet 2005; 366: 1561-1577.